最近在急性和慢性移植与宿主疾病的病理生理学的进展
Shuichiro Takahashi1, Daigo Hashimoto2
1Division of Hematology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
International journal of hematology
|February 13, 2026
概括
移植与宿主疾病 (GVHD) 复杂化了全原干细胞移植. 了解T细胞枯竭和干细胞再生为管理GVHD和改善移植成功提供了新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 移植生物学 移植生物学
- 干细胞研究 干细胞研究
背景情况:
- 移植与宿主疾病 (GVHD) 是所有原性造血细胞移植 (allo-HCT) 成功的重要障碍.
- 组织干细胞再生和免疫细胞动态在GVHD病变发生和解决过程中至关重要.
研究的目的:
- 阐明急性和慢性GVHD背后的机制.
- 探索组织干细胞和T细胞耗尽在GVHD中的作用.
- 确定GVHD管理的新型治疗点.
主要方法:
- 实验模型和临床研究的分析.
- 研究推动GVHD的细胞和分子机制.
- 评估GVHD后组织干细胞的表观遗传变化.
主要成果:
- 组织干细胞再生有助于GVHD耐受性.
- 干细胞的表观遗传变化可以加剧GVHD.
- 慢性GVHD涉及复杂的免疫失调,包括T细胞耗尽动态.
- 早期使用氨素抑制剂 (CNI) 可能会损害T细胞耗尽,促进慢性GVHD.
结论:
- 向组织干细胞功能和调节T细胞耗尽是对GVHD有希望的治疗途径.
- 优化免疫抑制策略,比如在基于PTCy的平台中延迟CNI启动,可以通过促进有益的T细胞耗尽来缓解慢性GVHD.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.7K
Acute Kidney Injury II: Pathophysiology
1.2K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.2K
Peptic Ulcer Disease II: Pathophysiology
2.2K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.2K
Coronary Artery Disease II: Pathophysiology
540
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
540
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
448
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
448
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
1.7K
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
1.7K


